This paper is in the following e-collection/theme issue:

Prostate Cancer (22) Mobile Apps for Cancer Care and Cancer Prevention and Screening (197) Innovations and Technology in Cancer Care (405) Innovations and Technology for Cancer Prevention and Screening (140)

Published on in Vol 7, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30430, first published .
Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review

Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review

Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review

Authors of this article:

Antonio Bandala-Jacques1, 2 Author Orcid Image ;   Kevin Daniel Castellanos Esquivel1 Author Orcid Image ;   Fernanda Pérez-Hurtado1 Author Orcid Image ;   Cristobal Hernández-Silva1 Author Orcid Image ;   Nancy Reynoso-Noverón1 Author Orcid Image
Article Authors Cited by (8) Tweetations (5) Metrics

Journals

  1. Tidd-Johnson A, Sebastian S, Co E, Afaq M, Kochhar H, Sheikh M, Mago A, Poudel S, Fernandez J, Rodriguez I, Razdan S. Prostate cancer screening: Continued controversies and novel biomarker advancements. Current Urology 2022;16(4):197 View
  2. Schenk J, Till C, Neuhouser M, Goodman P, Lucia M, Thompson I, Tangen C. Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention 2022;31(11):2063 View
  3. Saini S, Lewis C, Kerr E, Zikmund-Fisher B, Hawley S, Forman J, Zauber A, Lansdorp-Vogelaar I, van Hees F, Saffar D, Myers A, Gauntlett L, Lipson R, Kim H, Vijan S. Personalized Multilevel Intervention for Improving Appropriate Use of Colorectal Cancer Screening in Older Adults. JAMA Internal Medicine 2023;183(12):1334 View
  4. Baseilhac P, Rouvière O. Diagnostic du cancer de prostate : présent et futur. Médecine Nucléaire 2023;47(5):233 View
  5. Gómez Rivas J, Leenen R, Venderbos L, Helleman J, de la Parra I, Vasilyeva V, Moreno-Sierra J, Basu P, Chandran A, van den Bergh R, Collen S, Van Poppel H, Roobol M, Beyer K. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs. Journal of Personalized Medicine 2023;13(12):1677 View
  6. Hermanns T, Wettstein M, Kaufmann B, Lautenbach N, Kaufmann E, Saba K, Schmid F, Hötker A, Müntener M, Umbehr M, Poyet C. BioPrev-C – development and validation of a contemporary prostate cancer risk calculator. Frontiers in Oncology 2024;14 View
  7. Tosoian J, Zhang Y, Xiao L, Xie C, Samora N, Niknafs Y, Chopra Z, Siddiqui J, Zheng H, Herron G, Vaishampayan N, Robinson H, Arivoli K, Trock B, Ross A, Morgan T, Palapattu G, Salami S, Kunju L, Tomlins S, Sokoll L, Chan D, Srivastava S, Feng Z, Sanda M, Zheng Y, Wei J, Chinnaiyan A, Thompson I, Bidair M, Kibel A, Lin D, Lotan Y, Partin A, Taneja S, Howard D, Regan M, Groskopf J, Chipman J, Patil D, Scherr D, Kagan J, Fan J, Joon A, Bantis L, Rubin M. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncology 2024;10(6):726 View
  8. Chen C, Huang H, Chang K, Lee M, Lee C, Lin C, Lin Y, Huang W, Liao C, Yu C, Chung S, Tsai Y, Wu C, Ho C, Hsiao P, Pu Y. Predicting Clinically Significant Prostate Cancer Using Urine Metabolomics via Liquid Chromatography Mass Spectrometry. The World Journal of Men's Health 2024;42 View